The primary outcome was quality of life ( QoL ) , assessed using the European Organization for Research and Treatment of Cancer Global Quality of Life questionnaire C30 ( EORTC QLQ-C30 ) and the European Quality of Life Instrument ( EQ-5D ) tool ; secondary outcomes were nutritional status and survival .